Cut‐Offs and Diagnostic Performance of IgG Against Recombinant Aspergillus fumigatus Antigens in Differentiating ABPA From Asthma
Mycoses · 2025
DOI: 10.1111/myc.70087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Ritesh Agarwal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Aspergillus fumigatus, Immunoglobulin G, Antigens, Fungal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Indian Council of Medical Research, Postgraduate Institute of Medical Education and Research, Chandigarh.
Abstract (Originalsprache)
Background
The diagnostic cut‐off values for IgG antibodies against recombinant Aspergillus fumigatus (rAsp) antigens in allergic bronchopulmonary aspergillosis (ABPA) remain unclear.
Objectives
To derive and validate diagnostic cut‐offs for IgG antibodies against rAsp f 1, f 2 and f 4 in ABPA and assess their diagnostic performance in distinguishing ABPA from asthma.
Methods
In this case‐control study, we prospectively enrolled consecutive subjects with asthma and ABPA. We measured serum IgG levels against rAsp f 1, rAsp f 2 and rAsp f 4 using a fluorescent enzyme immunoassay. Subjects were randomly split into derivation (50%) and validation (50%) cohorts. Cut‐offs were derived using receiver operating characteristic (ROC) curves and Youden's index. Additionally, we performed Bayesian latent class analysis (BLCA) using two‐component Gaussian mixture models to derive unbiased cut‐offs. Diagnostic performance was assessed using sensitivity, specificity and the area under the ROC curve (AUROC).
Results
Of 375 participants, 261 had ABPA and 114 had asthma. ROC‐derived AUROC values for rAsp f 1, f 2 and f 4‐IgG were 0.63, 0.47 and 0.52, while the cut‐off values were 10.1 mgA/L, 10.3 mgA/L and 10.5 mgA/L, respectively. Sensitivity was ≤ 42% for all antigens, while specificity exceeded 89%. BLCA yielded cut‐offs of 18.6, 14.9 and 13.7 mgA/L for f 1, f 2 and f 4, respectively, with similarly poor sensitivity and high specificity.
Conclusions
IgG antibodies against rAsp f 1, f 2 and f 4 exhibit high specificity but poor sensitivity in identifying ABPA, limiting their utility as standalone diagnostic markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Doodhadhari Burfani Hospital, Haridwar, India.
ORCID-Profile: Ritesh Agarwal, Valliappan Muthu, Mandeep Garg, Arunaloke Chakrabarti
Förderung
- Indian Council of Medical Research
- Postgraduate Institute of Medical Education and Research, Chandigarh
Zitieren
APA
Agarwal, R., Muthu, V., Sehgal, I. S., Prasad, K. T., Dhooria, S., Singh, M., Garg, M., Aggarwal, A. N., Rudramurthy, S. M., & Chakrabarti, A. (2025). Cut‐Offs and Diagnostic Performance of IgG Against Recombinant Aspergillus fumigatus Antigens in Differentiating ABPA From Asthma. Mycoses. https://doi.org/10.1111/myc.70087
Vancouver
Agarwal R, Muthu V, Sehgal IS, Prasad KT, Dhooria S, Singh M, et al. Cut‐Offs and Diagnostic Performance of IgG Against Recombinant Aspergillus fumigatus Antigens in Differentiating ABPA From Asthma. Mycoses. 2025. doi:10.1111/myc.70087
BibTeX
@article{Agarwal2025,
author = {Agarwal, Ritesh and Muthu, Valliappan and Sehgal, Inderpaul Singh and Prasad, Kuruswamy Thurai and Dhooria, Sahajal and Singh, Mani and Garg, Mandeep and Aggarwal, Ashutosh N and Rudramurthy, Shivaprakash M and Chakrabarti, Arunaloke},
title = {Cut‐Offs and Diagnostic Performance of IgG Against Recombinant Aspergillus fumigatus Antigens in Differentiating ABPA From Asthma},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70087}
}
EUVIMED